Early stage Hodgkin lymphoma face a higher risk of death cardiovascular disease than from cancer

0 Views

07/09/23

Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but therapies can increase patients’ risk of developing heart problems. A recent study published online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals that people with early-stage Hodgkin's lymphoma are now at higher risk of dying from cardiovascular disease than from cancer.

The multicenter study included 15,889 children and adults in the United States who were diagnosed with Hodgkin lymphoma between 1983 and 2015. Researchers conducted this study because cardiovascular disease may be the most common non-malignant long-term complication and a prevalent cause for non-malignant death following treatment in Hodgkin lymphoma survivors.

Get the latest medical and health news at medicaldialogues.in
Follow us on
Twitter: https://twitter.com/medicaldialogs
Facebook: https://www.facebook.com/medicaldialogues/
Instagram: https://www.instagram.com/medicaldialogues
LinkedIn: https://www.linkedin.com/company/medical-dialogues
Website: https://medicaldialogues.in/